Overview

Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.

Status:
Completed
Trial end date:
2021-09-27
Target enrollment:
Participant gender:
Summary
A Phase 1, single center, single arm, open-label study to assess the PK, safety and tolerability of Aztreonam-Avibactam after single and repeated IV infusion of doses in healthy Chinese participants.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Avibactam
Aztreonam